Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
General Internal Medicine
•
Thrombosis
•
Hematology
•
Pediatric Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Are there any circumstances where you would consider bridging for patients on DOACs?
What if the surgery is within 30 days of the blood clot?
Related Questions
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
How would you manage elevated vWF and FVIII levels in a patient with a family history of coagulopathy?
Can lupus anticoagulant be positive despite a normal aPTT?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
How do you manage arthritis resulting from deferiprone in transfusion dependent thalassemia?
Would you evaluate for thrombophilia in patients with incidental splenic infarcts in the setting of known cirrhosis, portal hypertension, and splenomegaly?
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?